Utah Approves First AI-Prescribed Acne Meds

Nolla Health has become the first US company authorized by a state regulator to allow AI to issue initial prescriptions.

Previously, every prescription required a licensed clinician's signature. The new pilot permits the AI to generate prescriptions directly within strict limits (topical acne meds only), shifting doctors to after-the-fact or sample-based review.

The rollout has three stages: the first 100 patients require dual real-time physician approval; the next 500 involve direct AI issuance with weekly physician review; the final stage involves monthly audits of at least 10% of cases. Progression requires 95% agreement with physicians and zero serious adverse events.

This model addresses dermatologist shortages but explicitly excludes high-risk drugs like isotretinoin and severe cases.